Gernandt & Danielsson advised in private placement of shares in Medivir

Gernandt & Danielsson advised Carnegie Investment Bank AB and Jefferies International Limited in connection with the SEK 280 million private placement of class B shares in Medivir AB (publ). Medivir is an emerging research-based specialty pharmaceutical company focused on infectious diseases and is listed NASDAQ OMX Stockholm.

G&D’s team primarily consisted of responsible partner Fredrik Palm and associate Fredrik Eklund.